Cooperative Agreement FA2384262B002
- Federal Cooperative Agreement Summary The University of Cincinnati, through its Sponsored Research Services Division, received a $749,000 Cooperative Agreement from the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) to evaluate clinical and operational aspects of Aeropace diaphragmatic pacing. The award was established on March 17, 2026, with an ultimate completion date of July 17, 2029. Under this cooperative agreement, the university will conduct research...
- Federal Cooperative Agreement Summary The University of Cincinnati's Sponsored Research Services Division received an $800,000 Cooperative Agreement from the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800), awarded on March 17, 2026, with a completion date of March 17, 2028. This agreement funds research focused on evaluating a novel filter strategy to reduce antibody titers in donated blood, addressing a critical need in blood product processing and transfusion...
- This Cooperative Agreement award from the Air Force Defense Research Sciences Program (CFDA 12.800) provides $517,284.00 in funding to the University of Cincinnati to conduct an "Operational Capability Assessment of Fluid Warmers". The award period runs from September 19, 2023 to December 19, 2025. The University of Cincinnati, through its Sponsored Research Services division, is the prime awardee and will execute this research project. As the leading public research institution, the...
- The U.S. Department of the Air Force, through its Air Force Defense Research Sciences Program (CFDA 12.800), awarded a $349,910.00 cooperative agreement to the University of Cincinnati to conduct an "Evaluation of Allowance Standard Equipment in Extreme Cold Exposure" research project. The award, established as Agreement Order 17 under a basic cooperative agreement, has a period of performance from Apr 16, 2024 to Oct 16, 2025. The University of Cincinnati's Sponsored Research Services...
- Federal Cooperative Agreement Summary The University of Maryland, Baltimore received a $1,013,566 Cooperative Agreement from the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800), awarded June 11, 2025, with a completion date of December 11, 2026. While the specific research objectives are not detailed in the available documentation, the award supports fundamental and applied scientific research designed to enhance Department of the Air Force mission capabilities...
- Cooperative Agreement Summary The University of Maryland, Baltimore received an $848,000 Cooperative Agreement award from the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) effective April 29, 2025, with completion targeted for April 29, 2028. The award supports fundamental and applied scientific research focused on "Targeting Extracellular microRNAs (miRNAs) Sensing in Trauma-Induced Acute Lung Injury." This research aligns with the program's objective...
- The U.S. Air Force awarded a $1,758,800 Cooperative Agreement to the University of Cincinnati on June 12, 2024 under the Air Force Defense Research Sciences Program (CFDA 12.800). The funding supports the development of "Nanomedicine Systems for Targeted Treatment of TBI Plus Hemorrhagic Shock." The University of Cincinnati was also issued a $1,607,200 sub-award under this Cooperative Agreement on November 21, 2024 to further this research. As a leading public research institution, the...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $2,441,067 Cooperative Agreement to the University of Cincinnati under the Air Force Defense Research Sciences Program (CFDA 12.800) on September 24, 2024. The agreement is for the "Advanced Development of Autonomous Closed Loop Control (ACLC) Mechanical Ventilation (MV) Fraction-Inspired Oxygen (FIO2)", with a scheduled completion date of June 24, 2026. The University of Cincinnati, through its Sponsored...
- Federal Cooperative Agreement Summary The University of Maryland, Baltimore received a Cooperative Agreement (FA8650-25-2-6L13) valued at $1,973,263 from the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800), effective September 30, 2025, with a completion date of October 2, 2028. The award funds research focused on "Plasma microRNA Signatures of Human Trauma Immunity and Injury," which investigates the molecular and immunological responses to traumatic...
- This federal Cooperative Agreement award, with a total funding amount of $349,944.00, was granted by the U.S. Air Force under the Defense Research Sciences Program (CFDA 12.800) to the University of Cincinnati's Sponsored Research Services Division. The purpose of this award is to conduct an EVALUATION OF IMLIFIDASE TO REDUCE DONATED BLOOD ANTIBODY TITERS. The award period runs from April 16, 2024 to July 16, 2025. The University of Cincinnati is a leading research institution that frequently...
The University of Cincinnati's Sponsored Research Services Division received a $749,000 Cooperative Agreement from the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800), awarded March 17, 2026, with a completion date of July 17, 2029. The award funds a comprehensive bench testing study examining military medical operations within the en route care continuum. This research initiative supports the Air Force's objective to maintain technological superiority and enhance the Department of the Air Force's mission capabilities through peer-reviewed, competitive scientific research conducted at accredited educational institutions. The cooperative agreement structure indicates collaborative engagement between the University of Cincinnati and the Air Force to develop evidence-based solutions and testing methodologies for medical operations performed during patient transport in military settings. Given the Air Force Defense Research Sciences Program's emphasis on applied research that maintains technological advantage and builds research infrastructure, this bench testing study will generate empirical data and validated protocols applicable to military medical operations and en route care procedures, contributing to improved medical readiness and operational effectiveness across Air Force medical systems.Federal Cooperative Agreement Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/31/26 | ||
| Not listed | $749.0k | 3/19/26 |